Laboratorios Farmaceuticos Rovi
ROVI.MC
#3554
Rank
NZ$5.22 B
Marketcap
$102.13
Share price
2.63%
Change (1 day)
-23.74%
Change (1 year)

P/S ratio for Laboratorios Farmaceuticos Rovi (ROVI.MC)

P/S ratio as of March 2025 (TTM): 3.34

According to Laboratorios Farmaceuticos Rovi's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.69. At the end of 2024 the company had a P/S ratio of 4.67.

P/S ratio history for Laboratorios Farmaceuticos Rovi from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.6721.85%
20233.8367.59%
20222.29-62.38%
20216.0814.86%
20205.29